>>Signaling Pathways>> Immunology/Inflammation>> NF-κB>>Deoxyelephantopin

Deoxyelephantopin

Catalog No.GC60129

Elephantopus scaber의 천연 생리 활성 세스퀴테르펜 락톤인 데옥시엘레판토핀은 광범위한 암에 대해 유망한 항암 효과를 보여주었습니다. 데옥시엘레판토핀은 NF-κB, MAPK, PI3K/Akt 및 β-카테닌 신호전달을 억제합니다.

Products are for research use only. Not for human use. We do not sell to patients.

Deoxyelephantopin Chemical Structure

Cas No.: 29307-03-7

Size 가격 재고 수량
10mM (in 1mL DMSO)
US$231.00
재고 있음
1mg
US$84.00
재고 있음
5mg
US$210.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Deoxyelephantopin, a natural bioactive sesquiterpene lactone from Elephantopus scaber, has shown promising anticancer effects against a broad spectrum of cancers. Deoxyelephantopin inhibits NF-κB, MAPK, PI3K/Akt, and β-catenin signaling[1].

Deoxyelephantopin inhibits the cell growth of HCT 116 (colorectal), K562 (chronic myeloid leukemia), KB (oral), and T47D (breast) cancer cell lines with IC50s of 7.46, 4.02, 3.35, 1.86 μg/mL, respectively[1].Deoxyelephantopin increases the expression of p53, p-JNK, and p-p38 and decreases the expression of p-STAT3 and p-mTOR in cancer cells. Deoxyelephantopin downregulates MMP-2 and MMP-9, uPA, and uPAR mRNA levels in cancer cells[1].

[1]. Farha Arakkaveettil Kabeer, et al. Molecular Mechanisms of Anticancer Activity of Deoxyelephantopin in Cancer Cells. Integr Med Res. 2017 Jun;6(2):190-206.

리뷰

Review for Deoxyelephantopin

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Deoxyelephantopin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.